What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;

Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease Diego García-Compeán; Emanuela Orsi; Tsutomu Nishida; Ramesh Kumar;

The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;